Literature DB >> 8690902

Phenotype and function of CD4+ T cells in mice lacking invariant chain.

P Wong1, A Y Rudensky.   

Abstract

Mice bearing a targeted disruption of the gene encoding the invariant chain (Ii) have provided a deeper understanding of the critical role that Ii plays in the assembly, transport, and peptide occupancy of MHC class II molecules. In this study, we have investigated the consequence of the altered class II expression in Ii-deficient (Ii zero) mice on the phenotype and function of their CD4+ T cells. As seen by others, these mice show a sharp reduction in the CD4+8- subset in the thymus and periphery. Furthermore, a large proportion of the peripheral CD4+, but not CD8+, T cells in Ii zero mice exhibit decreased surface TCR-alpha beta levels and express markers of T cell activation. Although the CD4+ T cells respond to mitogens, anti-CD3 mAbs, and alloantigens, they respond poorly to the bacterial superantigen staphylococcal enterotoxin B and do not respond to peptide and protein Ags. Analysis of reciprocal radiation bone marrow chimeras constructed using Ii zero and wild-type mice indicate that the lack of Ii in the thymus is responsible for the phenotype of the CD4+ T cells in mutant mice. These results suggest that the altered thymic peptide repertoire displayed by class II molecules in the absence of Ii has a dramatic impact on the selection of CD4+ T cells and their phenotype in the periphery.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690902

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Homeostatic expansion and phenotypic conversion of naïve T cells in response to self peptide/MHC ligands.

Authors:  W C Kieper; S C Jameson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

2.  CD74 Deficiency Mitigates Systemic Lupus Erythematosus-like Autoimmunity and Pathological Findings in Mice.

Authors:  Yi Zhou; Huimei Chen; Li Liu; Xueqing Yu; Galina K Sukhova; Min Yang; Lijun Zhang; Vasileios C Kyttaris; George C Tsokos; Isaac E Stillman; Takaharu Ichimura; Joseph V Bonventre; Peter Libby; Guo-Ping Shi
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

Review 3.  Searching for genes involved in the pathogenesis of primary immunodeficiency diseases: lessons from mouse knockouts.

Authors:  C M Kokron; F A Bonilla; H C Oettgen; N Ramesh; R S Geha; F Pandolfi
Journal:  J Clin Immunol       Date:  1997-03       Impact factor: 8.317

4.  The Ii41 isoform of invariant chain mediates both positive and negative selection events in T-cell receptor transgenic mice.

Authors:  R J Wright; E K Bikoff; B Stockinger
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

Review 5.  MHC class II antigen presentation and immunological abnormalities due to deficiency of MHC class II and its associated genes.

Authors:  Xinjian Chen; Peter E Jensen
Journal:  Exp Mol Pathol       Date:  2008-04-13       Impact factor: 3.362

6.  T helper subset differentiation in the absence of invariant chain.

Authors:  D R Brown; K Swier; N H Moskowitz; M F Naujokas; R M Locksley; S L Reiner
Journal:  J Exp Med       Date:  1997-01-06       Impact factor: 14.307

7.  The somatically generated portion of T cell receptor CDR3α contributes to the MHC allele specificity of the T cell receptor.

Authors:  Philippa Marrack; Sai Harsha Krovi; Daniel Silberman; Janice White; Eleanor Kushnir; Maki Nakayama; James Crooks; Thomas Danhorn; Sonia Leach; Randy Anselment; James Scott-Browne; Laurent Gapin; John Kappler
Journal:  Elife       Date:  2017-11-17       Impact factor: 8.140

8.  MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells.

Authors:  Shouxiong Huang; Susan Gilfillan; Sojung Kim; Bruce Thompson; Xiaoli Wang; Andrea J Sant; Daved H Fremont; Olivier Lantz; Ted H Hansen
Journal:  J Exp Med       Date:  2008-04-28       Impact factor: 14.307

Review 9.  Exposing the Specific Roles of the Invariant Chain Isoforms in Shaping the MHC Class II Peptidome.

Authors:  Jean-Simon Fortin; Maryse Cloutier; Jacques Thibodeau
Journal:  Front Immunol       Date:  2013-12-13       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.